Discovered by BIOTEC research team together with the Medicines for Malaria Venture (MMV), the patented P218 compound was designed based-on 3-dimensional structures of malaria protein target, dihydrofolate reductase, in order to circumvent mutations that had led to resistance to pyrimethamine, […]
Recent Posts
- BIOTEC invites you to register for the international conference on Rice Cultivation and Vegetable Science & Innovation
09/11/2025 - BIOTEC and XTBG Strengthen Collaboration in Forest Ecology and Plant Research
09/10/2025 - Regional Knowledge Sharing Workshop: Scaling Low-Emission Rice Cultivation Technologies and Practices in South and Southeast Asia
08/05/2025